Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Patent
1997-08-14
2000-11-28
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
424422, 424424, 424425, 424426, 424435, 424444, 424445, A61K 3338, A61K 970, A61K 31765, A61L 1503
Patent
active
06153210&
ABSTRACT:
Periodontal disease can be treated by the administration of metal ions, preferably silver ions, to the site where the microorganisms that cause this disease reside. Administration can be to periodontal pockets or adjacent to exposed tooth roots or alveolar bone during periodontal surgical procedures. The metal ions can be administered in polymeric microparticles, deformable films or microparticles embedded within deformable films. The metal ions are particularly microbiocidal to the bacterial pathogens that are the causative agents of periodontal disease.
REFERENCES:
patent: Re33093 (1989-10-01), Schiraldi et al.
patent: 3337405 (1967-08-01), Netien
patent: 3419006 (1968-12-01), King
patent: 3639575 (1972-02-01), Schmolka
patent: 3739773 (1973-06-01), Schmitt et al.
patent: 3875937 (1975-04-01), Schmitt et al.
patent: 4376764 (1983-03-01), Schmolka
patent: 4476590 (1984-10-01), Scales et al.
patent: 4559223 (1985-12-01), Fox
patent: 4569837 (1986-02-01), Suzuki et al.
patent: 4570629 (1986-02-01), Widra
patent: 4588400 (1986-05-01), Ring et al.
patent: 4685883 (1987-08-01), Jernberg
patent: 4713243 (1987-12-01), Schiraldi et al.
patent: 4728323 (1988-03-01), Matson
patent: 4764377 (1988-08-01), Goodson
patent: 4780320 (1988-10-01), Baker
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4846165 (1989-07-01), Hare et al.
patent: 4847049 (1989-07-01), Yamamoto
patent: 4892736 (1990-01-01), Goodson
patent: 4906670 (1990-03-01), Higashi et al.
patent: 4919939 (1990-04-01), Baker
patent: 4933182 (1990-06-01), Higashi et al.
patent: 4978391 (1990-12-01), Jones
patent: 4981693 (1991-01-01), Higashi et al.
patent: 4997425 (1991-03-01), Shioya et al.
patent: 5009898 (1991-04-01), Sakuma et al.
patent: 5019096 (1991-05-01), Fox et al.
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5059123 (1991-10-01), Jernberg
patent: 5077049 (1991-12-01), Dunn et al.
patent: 5102666 (1992-04-01), Acharya
patent: 5108399 (1992-04-01), Eitenmuller et al.
patent: 5149469 (1992-09-01), Komatsuzaki et al.
patent: 5197882 (1993-03-01), Jernberg
patent: 5236355 (1993-08-01), Brizzolara et al.
patent: 5260066 (1993-11-01), Wood et al.
patent: 5298015 (1994-03-01), Komatsuzaki et al.
patent: 5298237 (1994-03-01), Fine
patent: 5326567 (1994-07-01), Capelli
patent: 5340581 (1994-08-01), Tseng et al.
patent: 5366733 (1994-11-01), Brizzolara et al.
patent: 5387419 (1995-02-01), Levy et al.
patent: 5468489 (1995-11-01), Sakuma et al.
patent: 5534288 (1996-07-01), Gruskin
patent: 5571521 (1996-11-01), Lasker
patent: 5620700 (1997-04-01), Berggren et al.
patent: 5622498 (1997-04-01), Brizzolara et al.
patent: 5688492 (1997-11-01), Galley et al.
patent: 5707962 (1998-01-01), Chen et al.
patent: 5783205 (1998-07-01), Berggren et al.
patent: 5955097 (1999-09-01), Tapolsky et al.
Merckinder Merck & Co. 11.sup.th Ed 8450 846484658 468 84738470 8475 Silver Compounds Topical Antiseptic, 84638462 84608 84578455 Silver Nitrate, etc. 8452 8451, 1989.
Fung et al. JL. Toxicology Clinical Toxicology 34(1): 119-126 Silver Products for Medical Indications: Risk-Benefit Ass; Silver Nitrate-Silver Sulfadiazine-Silver Protein (Mild)-Colloidal Silver (CSP), 1996.
Russell Progress in Medicinal Chemistry 31:351-370 Antimicrobial Activity and Action of Silver Silver Nitrate Silver Protein Silver Sulfadiazine Colloidal Silver, 1994.
Fung et al Journal of Toxicology Clinical Toxicology 34(1): 119-126 Silver Products for Medical Indications: Risk Benefit Assessment, 1996.
Rusch-Behrend et al Quintessence International 26(8): 553-557 Management of Diffuse Tissue Argyria Subsequent to Endodontic Therapy: Report of a Case, Aug. 1995.
Kirchoff Oral Surgery, Oral Medicine and Oral Pathology 32(4): 613-617 Localized Argyria After a Surgical Endodontic Procedure Report of a Case, Oct. 1971.
Chan Georgetown Dental Journal 62(2): 31-35 Amalgam Tattoos (Localized Argyria): A Review of the Literature, Jul. 1978.
Mack North Carolina Medical Journal 49(9): 451-452 Argyroc and Argyria Return With Us Now to Those Thrilling Days of Yesteryear, Sep. 1988.
Hudson et al Australian and New Zealand Jl. of Ophthalmology(4): 391-394 Argyrol Argyrosis and the Acquisition of Art, Nov. 1985.
Dummett Postgraduate Medicine 49(1): 78-82 Systematic Significance of Oral Pigmentation and Discoloration, Jan. 1971.
Marshall et al Archives of Dermatology 113(8): 1077-1079 Systemic Argyria Secondary to Topical Silver Nitrate, Aug. 1977.
Lee et al Jl. of Dermatology 21(1): 50-53 Generalized Argyria After Habitual Use of AgNO3, Jan. 1994.
Jurizcka Haut Arzt 37(11): 628-631 Generalized Argyrosis, Nov. 1986.
MacIntire et al British Medical Journal 2(6154) : 1749-1750 Silver Poisoning Associated with an Antismoking Lozenge, Dec. 23-30, 1978.
Shelton et al British Medical Journal 1 (6158) : 267 Silver Poisoning Associated With an Antismoking Lozenge, Jan. 27, 1979.
Prescott et al Jl. Clin. Pathology 47(6): 556-557 Systemic Argyria, Jun. 1994.
Greene et al American Family Physician 36(6) : 151-154 Argyria, Dec. 1987.
Westhofen et al Areh. Oto-Rhino-caryngology 243(4)260-264 Generalized Argyrosis in Man, 1986.
Capoen et al Arhiu Franc. de Pediatrie 46(1): 49-50 Agryria in Children, Jan. 1989.
Zech et al Nouv. Press Medicine 2 (3) : 161-164 Generalized Argyria Silver mouthwash, Jan. 1973.
Williams, R., Medical Progress: Periodontal Disease, N Engl J Med., 322:373-382 (1990).
Thibodeau, E. A., et al. "Inhibition and Killing of Oral Bacteria by Silver Ions Generated with Low Intensity Direct Current," J Dent Res., 57(9-10): 922-926 (1978).
Russell, A.D. and Hugo, W.B., "Antimicrobial Activity and Action of Silver," Prog Med Chem., 31: 351-370 (1994).
Howell, T.H., et al., "Sulfadiazines reduce gingivitis and plaque formation in beagle dogs," J Clin Periodontol., 17: 734-737 (1990).
Howell, T.H., et al., "Sulfadiazines prevent plaque formation and gingivitis in beagles," J Periodont Res., 25: 197-200 (1990).
Friden Phillip M.
Nelson Eric
Roberts F. Donald
Spacciapoli Peter
Periodontix, Inc.
Rose Shep K.
LandOfFree
Use of locally delivered metal ions for treatment of periodontal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of locally delivered metal ions for treatment of periodontal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of locally delivered metal ions for treatment of periodontal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1722249